LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel ; Online: The outcomes of bilateral bone conduction hearing devices (BCHD) implantation in the treatment of hearing loss: A systematic review.

    Heath, Ella / Dawoud, Moustafa Mohamed / Stavrakas, Marios / Ray, Jaydip

    Cochlear implants international

    2021  Band 23, Heft 2, Seite(n) 95–108

    Abstract: Objectives: Bone Conduction Hearing Devices (BCHDs) are a means of improving hearing ability in those that do not receive full benefit from conventional hearing aids. In 2016, the NHS started commissioning bilateral BCHDs. This review aims to evaluate ... ...

    Abstract Objectives: Bone Conduction Hearing Devices (BCHDs) are a means of improving hearing ability in those that do not receive full benefit from conventional hearing aids. In 2016, the NHS started commissioning bilateral BCHDs. This review aims to evaluate the current literature and identify areas for further research.
    Methods: This review was conducted in line with the PRISMA guidelines and registered on the PROSPERO database (registration CRD42020191956). MEDLINE, CINAHL and The Cochrane Library were systematically searched. The full text of relevant titles and abstracts was then reviewed before data extraction was undertaken. Risk of bias was assessed using the ROBINS-1 tool.
    Results: Searches identified 125 studies. After removing duplicates, 28 full texts were screened. 14 studies were included in the final review. Amongst the audiological outcomes, greater improvements for bilateral compared to unilateral BCHDs were seen in hearing thresholds, understanding speech in quiet, localization, and restoration of binaural hearing. Thus, supporting the addition of a second implant. For speech in noise however, bilateral BCHDs were less effective when the noise was presented from one side. Increases in measures of Quality of Life, including the Glasgow Benefit Index, were seen across all included studies. No studies included complication rates.
    Conclusion: Overall, bilateral BCHDs offer benefits to the recipient's audiological capabilities and QoL. However, more research is required on the complications and the cost of bilateral BCHDs. Further to this, future research should aim to use uniform tests to measure outcomes.
    Mesh-Begriff(e) Bone Conduction ; Cochlear Implantation ; Deafness ; Hearing Aids ; Hearing Loss ; Hearing Loss, Bilateral ; Humans ; Quality of Life ; Speech Perception
    Sprache Englisch
    Erscheinungsdatum 2021-12-01
    Erscheinungsland England
    Dokumenttyp Journal Article ; Systematic Review
    ZDB-ID 2079515-4
    ISSN 1754-7628 ; 1467-0100
    ISSN (online) 1754-7628
    ISSN 1467-0100
    DOI 10.1080/14670100.2021.2001926
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: First United Kingdom experience of the novel Osia active transcutaneous piezoelectric bone conduction implant.

    Lau, Kimberley / Scotta, Gianluca / Wright, Kay / Proctor, Vicki / Greenwood, Larissa / Dawoud, Moustafa / Ray, Jaydip

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

    2020  Band 277, Heft 11, Seite(n) 2995–3002

    Abstract: Purpose: Bone conduction hearing devices are widely used and indicated in cases of conductive, mixed or single-sided deafness where the conventional hearing aids are not indicated or tolerated. This prospective study aims to investigate the surgical and ...

    Abstract Purpose: Bone conduction hearing devices are widely used and indicated in cases of conductive, mixed or single-sided deafness where the conventional hearing aids are not indicated or tolerated. This prospective study aims to investigate the surgical and hearing outcomes of a novel active piezoelectric transcutaneous bone conduction device (t-BCD).
    Methods: Prospective data were collected from the first 10 patients who underwent implantation with the t-BCD Osia (Cochlear, Australia) (between Dec 2018 and March 2019) in a tertiary referral centre. The main outcome measures include: surgical outcome, free field speech testing with speech recognition thresholds, audiological gain and patient-reported outcomes including the 'Glasgow Benefit Inventory' (GBI) and the 'Client Oriented Scale of Improvement (COSI).
    Results: The mean length of surgery was 70.6 min (range 50-87, SD = 9.5). Mean skin thickness measured was 5.6 mm (range 4-8, SD = 1.1). There were two post-operative wound infections which settled conservatively. One required revision surgery to thin skin. The average gain in hearing with the implant was + 39.4 dB. Pre-implantation mean unaided SRT was 38.1 dB (SD = 7.8) and the post-implantation mean-aided SRT was 22.7 dB (SD = 4.6) (p = 0.000078). There was improvement in COSI domains. The mean Glasgow disability score dropped from 52% pre-implantation to 20% post-implantation (p = 0.001).
    Conclusions: This new active t-BCHD provides excellent audiological gain and improvement in speech recognition. Patient-reported outcomes have also been very positive. The surgery was straightforward with no major surgical complications reported. Further studies will be required to examine long-term outcomes in larger number of patients.
    Mesh-Begriff(e) Australia ; Bone Conduction ; Hearing Aids ; Hearing Loss, Conductive/surgery ; Humans ; Prospective Studies ; Speech Perception ; Treatment Outcome ; United Kingdom
    Sprache Englisch
    Erscheinungsdatum 2020-05-13
    Erscheinungsland Germany
    Dokumenttyp Journal Article
    ZDB-ID 1017359-6
    ISSN 1434-4726 ; 0937-4477
    ISSN (online) 1434-4726
    ISSN 0937-4477
    DOI 10.1007/s00405-020-06022-7
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang